Research Topics
| Marcello TonelliSummaryAffiliation: University of Alberta Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Indigenous health: update on the impact of diabetes and chronic kidney diseaseKaren Yeates
Department of Medicine, Queens University, Kingston, Ontario, Canada
Curr Opin Nephrol Hypertens 15:588-92. 2006..The impact on healthcare systems in countries where these indigenous populations reside will be substantial unless significant efforts are made to improve diabetic renal disease outcomes in the near future...
A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomesNatasha Wiebe
Department of Medicine, 13 103 Clinical Sciences Building, University of Alberta, Edmonton, Alberta, T6G 2G3 Canada
BMC Med 9:123. 2011..The major metabolic complications of obesity and type 2 diabetes may be prevented and managed with dietary modification. The use of sweeteners that provide little or no calories may help to achieve this objective...
Trace elements in hemodialysis patients: a systematic review and meta-analysisMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
BMC Med 7:25. 2009..We conducted a systematic review to summarize existing literature on trace element status in hemodialysis patients...
Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortalityMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Circulation 120:1784-92. 2009..Higher levels of serum alkaline phosphatase (AlkP) are associated with excess mortality in dialysis patients, but whether AlkP is associated with adverse outcomes among people without kidney failure is unknown...
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysisMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alta
CMAJ 183:E1189-202. 2011..We did a systematic review of randomized trials to assess the efficacy and harms of statins in these individuals...
Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United StatesMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada
JAMA 301:1681-90. 2009..US residents with end-stage renal disease (ESRD) may live far away from the closest transplant center, which could compromise their access to kidney transplantation...
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysisMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton
CMAJ 180:E62-71. 2009..However, their safety and effectiveness is controversial. We did a systematic review of the clinical efficacy and harms of these agents in adults with anemia related to cancer or chemotherapy...
Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysisMarcello Tonelli
Division of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Alta
CMAJ 177:1039-44. 2007..We investigated whether patients receiving hemodialysis who live farther from their attending nephrologist are more likely to die than those who live closer...
Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuriaMarcello Tonelli
Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
Kidney Int 80:1306-14. 2011..We do not know, however, whether the finding at higher eGFR could be due to inadequacies of the eGFR formula at low serum creatinine levels...
Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomesAminu K Bello
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Clin J Am Soc Nephrol 6:1418-26. 2011..Most studies of chronic kidney disease (CKD) and outcomes focus on mortality and ESRD, with limited data on other adverse outcomes. This study examined the associations among proteinuria, eGFR, and adverse cardiovascular (CV) events...
Relation between kidney function, proteinuria, and adverse outcomesBrenda R Hemmelgarn
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
JAMA 303:423-9. 2010..Although proteinuria is also associated with adverse outcomes, it is not used to refine risk estimates of adverse events in this current system...
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary diseaseMarcello Tonelli
Division of Nephrology and Division of Critical Care Medicine, University of Alberta, and Institute of Health Economics, Edmonton, Alberta, Canada
Circulation 112:171-8. 2005..We performed this analysis to determine whether pravastatin reduced the rate of kidney function loss over approximately 5 years in people with or at high risk for coronary disease...
Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiographyMatthew T James
Department of Medicine, University of Calgary, Calgary, Canada
Circulation 123:409-16. 2011..Acute kidney injury (AKI) is associated with early mortality after percutaneous coronary revascularization procedures, but its prognostic relevance to long-term clinical outcomes remains controversial...
Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort studyMatthew T James
Department of Medicine, University of Calgary, Calgary, AB, Canada
Lancet 376:2096-103. 2010..We aimed to investigate how eGFR and proteinuria jointly modified the risks of acute kidney injury and subsequent adverse clinical outcomes...
Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort studySabin Shurraw
Divisions of Nephrology, University of Alberta, Edmonton, Canada
Arch Intern Med 171:1920-7. 2011..Whether a lower HbA(1c) level improves outcomes in people with DM and chronic kidney disease (CKD) is unknown...
An economic evaluation of erythropoiesis-stimulating agents in CKDFiona M Clement
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
Am J Kidney Dis 56:1050-61. 2010..9 g/dL), intermediate (11-12 g/dL), or high (> 12 g/dL) hemoglobin level target compared with a strategy of managing anemia without ESAs...
Use and outcomes of peritoneal dialysis among Aboriginal people in CanadaMarcello Tonelli
Division of Nephrology, University of Alberta, 7 129 Clinical Science Building 8440, 112 Street, Edmonton, Alberta T6G 2G3 Canada
J Am Soc Nephrol 16:482-8. 2005..Future studies should address barriers to the initiation and maintenance of PD in the Aboriginal population, especially those who reside in rural locations...
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery diseaseJustin Ezekowitz
Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada T6G 2R7
J Am Coll Cardiol 44:1587-92. 2004..Patients with renal insufficiency are less likely to be prescribed efficacious therapies, but have better outcomes if they receive these medications...
NSAID use and progression of chronic kidney diseaseKatherine Gooch
Institute of Health Economics, Edmonton, Alberta, Canada
Am J Med 120:280.e1-7. 2007..Due to the high prevalence of both CKD and NSAID use in older adults, we sought to determine the association between NSAID use and the progression of CKD in an elderly community-based cohort...
Wait-listing for kidney transplantation among Aboriginal hemodialysis patientsMarcello Tonelli
Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada
Am J Kidney Dis 46:1117-23. 2005..We investigated barriers to kidney transplantation for Aboriginal patients treated with hemodialysis for ESRD in Canada...
Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in CanadaBrenda R Hemmelgarn
Department of Medicine, Division of Nephrology, University of Calgary, Canada
Am J Kidney Dis 48:964-71. 2006..Racial differences in health outcomes in general are well documented; however, few studies examined the impact of East Asian and Indo Asian race on choice of dialytic modality and survival among patients with end-stage renal disease (ESRD)...
The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trialMichael Walsh
Department of Medicine, University of Calgary, Alberta, Canada
Hemodial Int 14:174-81. 2010..The effects of NHD on PTH are variable. The impact of these changes on long-term cardiovascular and bone-related outcomes requires further investigation...
Quality of care and mortality are worse in chronic kidney disease patients living in remote areasDiana Rucker
Department of Medicine, University of Alberta, Alberta, Canada
Kidney Int 79:210-7. 2011....
Effect of pravastatin in people with diabetes and chronic kidney diseaseMarcello Tonelli
Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
J Am Soc Nephrol 16:3748-54. 2005..Additional studies are needed to determine whether these benefits apply to patients with more severe CKD, and recruitment to such studies should be given high priority...
The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trialMelissa Schorr
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
J Ren Nutr 21:271-6. 2011..More frequent dialysis may improve nutrition and remove dietary restrictions in hemodialysis (HD) patients. We present results from a trial comparing nutritional parameters between nocturnal hemodialysis (NHD) and conventional HD patients...
Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysisJaspreet Khangura
Department of Medicine, University of British Columbia, Vancouver, Canada
BMC Nephrol 11:13. 2010..We sought to determine agreement between various blood pressure measurement methods, as well as identify which method was the strongest correlate of LV hypertrophy among patients on hemodialysis...
Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rateBrenda R Hemmelgarn
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
JAMA 303:1151-8. 2010..Laboratory reporting of estimated glomerular filtration rate (GFR) has been widely implemented, with limited evaluation...
Prevalence of chronic kidney disease and survival among aboriginal peopleSong Gao
Department of Medicine, Division of Nephrology, University of Calgary, Calgary, Alberta, Canada
J Am Soc Nephrol 18:2953-9. 2007....
Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort studyMarcello Tonelli
University of Alberta, Edmonton, Canada
Ann Intern Med 154:12-21. 2011..The staging system for chronic kidney disease relies almost exclusively on estimated glomerular filtration rate (eGFR), although proteinuria is also associated with adverse outcomes...
Residence location and likelihood of kidney transplantationMarcello Tonelli
Division of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Alta
CMAJ 175:478-82. 2006..Within each region we also determined whether distance from the closest transplant centre was associated with the likelihood of transplantation...
CKD and risk of hospitalization and death with pneumoniaMatthew T James
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Am J Kidney Dis 54:24-32. 2009..The objective of this study is to determine the associations between estimated glomerular filtration rate (eGFR) and hospitalization or death with pneumonia...
Economic evaluation of erythropoiesis-stimulating agents for anemia related to cancerScott Klarenbach
Department of Medicine, University of Alberta Edmonton, Alberta, Canada
Cancer 116:3224-32. 2010..Concerns about toxicity have led to more restrictive recommendations for ESA use; however, the incremental costs and benefits of such a strategy are unknown...
Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysisDavina J Tai
Division of Nephrology, Foothills Medical Centre, 1403 29th Street NW, Calgary, Alberta, Canada, T2N 2T9
Clin J Am Soc Nephrol 5:623-30. 2010..This meta-analysis was performed to determine whether angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) reduce fatal and nonfatal CV events and left ventricular (LV) mass in patients receiving HD...
Relation between serum phosphate level and cardiovascular event rate in people with coronary diseaseMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Circulation 112:2627-33. 2005..Given the biological importance of phosphorus, it is plausible that higher levels of serum phosphate within the normal range may also be associated with adverse outcomes...
Modeling survival of arteriovenous accesses for hemodialysis: semiparametric versus parametric methodsPietro Ravani
Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Centre, 1403 29th St NW, Calgary, AB, T2N2T9, Canada
Clin J Am Soc Nephrol 5:1243-8. 2010..Comparing outcomes of arteriovenous grafts and fistulas is challenging because the pathophysiology of access dysfunction and failure rate profiles differ by access type. Studying how risks vary over time may be important...
Nocturnal hypoxia and loss of kidney functionSofia B Ahmed
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
PLoS ONE 6:e19029. 2011..Although obstructive sleep apnea (OSA) is more common in patients with kidney disease, whether nocturnal hypoxia affects kidney function is unknown...
Effect of pravastatin on cardiovascular events in people with chronic kidney diseaseMarcello Tonelli
Division of Nephrology, University of Alberta, 7 129 Clinical Science Building, 8440 112 St, Edmonton, Alberta T6G 2G3, Canada
Circulation 110:1557-63. 2004..The objective of this analysis was to determine whether pravastatin reduced the incidence of cardiovascular events in people with or at high risk for coronary disease and with concomitant moderate CKD...
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trialBruce F Culleton
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
JAMA 298:1291-9. 2007..Morbidity and mortality rates in hemodialysis patients remain excessive. Alterations in the delivery of dialysis may lead to improved patient outcomes...
A novel technique to optimize facility locations of new nephrology services for remote areasBharati Ayyalasomayajula
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Clin J Am Soc Nephrol 6:2157-64. 2011....
Acute kidney injury following coronary angiography is associated with a long-term decline in kidney functionMatthew T James
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Kidney Int 78:803-9. 2010..8 ml/min following moderate to severe acute kidney injury. Thus, acute kidney injury following coronary angiography is associated with a sustained loss and a larger rate of future decline in kidney function...
Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trialMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, AB, Canada T6G2C3
BMJ 332:1426. 2006..CONCLUSIONS: The presence or absence of proteinuria on dipstick urinalysis may be used to refine estimates of risk based on kidney function alone...
Overview of the Alberta Kidney Disease NetworkBrenda R Hemmelgarn
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
BMC Nephrol 10:30. 2009..The Alberta Kidney Disease Network is a collaborative nephrology research organization based on a central repository of laboratory and administrative data from the Canadian province of Alberta...
Factors associated with access blood flow in native vessel arteriovenous fistulaeMarcello Tonelli
Department of Medcine, University of Alberta, Edmonton, Alberta T6G 2G3, Canada
Nephrol Dial Transplant 19:2559-63. 2004..Such factors could be used in conjunction with Qa to improve the diagnostic performance of screening. We examined the relationship between Qa and certain clinical characteristics in a large group of patients with AVF...
Economic evaluation of sevelamer in patients with end-stage renal diseaseBraden Manns
Department of Community Health Sciences, University of Alberta, Edmonton, Alberta T6B 2b7 Canada
Nephrol Dial Transplant 22:2867-78. 2007..To account for uncertainty, we considered four separate modelling strategies, obtaining data on the relative effectiveness of sevelamer from the recent Dialysis Clinical Outcomes Revisited study...
Validation of a case definition to define chronic dialysis using outpatient administrative dataFiona M Clement
Department of Medicine, University of Calgary, 2500 University Dr NW, Calgary, Alberta, T2N 1N4, Canada
BMC Med Res Methodol 11:25. 2011..The objective of this study is to determine the validity of outpatient physician billing derived algorithms for defining chronic dialysis compared to a reference standard ESRD registry...
Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysisMatthew T James
Department of Medicine, University of Calgary, Foothills Medical Center, 1403 29th St NW, Calgary, AB T2N 2T9, Canada
Arch Intern Med 168:2333-9. 2008..Whether patients with chronic kidney disease who are not receiving dialysis are also at increased risk of bloodstream infection is less clear...
Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patientsMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Canada
Am J Kidney Dis 54:1108-15. 2009..Whether modifying dialysis prescription to intensify small-solute clearance also leads to better phosphate clearance is unknown...
Population based screening for chronic kidney disease: cost effectiveness studyBraden Manns
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
BMJ 341:c5869. 2010..To determine the cost effectiveness of one-off population based screening for chronic kidney disease based on estimated glomerular filtration rate...
Death and renal transplantation among Aboriginal people undergoing dialysisMarcello Tonelli
Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alta
CMAJ 171:577-82. 2004..We evaluated differences in survival and rate of renal transplantation among Aboriginal and white patients after initiation of dialysis...
Biomarkers of inflammation and progression of chronic kidney diseaseMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Kidney Int 68:237-45. 2005..We examined the association between pravastatin use, levels of C-reactive protein (CRP), soluble tumor necrosis factor receptor II (sTNFrii), and the rate of kidney function loss...
Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular diseaseMarcello Tonelli
University of Alberta, Edmonton, Alberta, Canada
J Am Soc Nephrol 14:1605-13. 2003..These findings require confirmation by a large randomized trial conducted specifically in people with chronic renal insufficiency...
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysisFinlay A McAlister
Division of General Internal Medicine and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alta
CMAJ 183:655-62. 2011..This study was designed to determine the safety of combination therapy with these two drugs in clinical practice...
Similar outcomes among black and white renal allograft recipientsKaren Yeates
Department of Medicine, Queen s University, 94 Stuart Street, Kingston, Ontario, Canada
J Am Soc Nephrol 20:172-9. 2009..Because this differs from the experience reported from the United States, further direct comparisons between the two populations is warranted...
Association between multidisciplinary care and survival for elderly patients with chronic kidney diseaseBrenda R Hemmelgarn
Department of Medicine, Community Health Schiences, University of Calgary, Calgary, Canada
J Am Soc Nephrol 18:993-9. 2007..The benefits of MDC and an assessment of their economic impact should be tested in a randomized, controlled trial...
The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantationJohn S Gill
Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada
Kidney Int 68:2345-51. 2005..Longer waiting times may limit the survival benefit of kidney transplantation in older patients or those with a high burden of comorbid disease...
Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysisVinay Deved
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Am J Kidney Dis 54:1089-97. 2009..Ascorbic acid is believed to improve anemia in patients with end-stage renal disease, but its overall effectiveness is unclear...
The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysisFiona M Clement
Departments of Community Health Sciences and Medicine, Centre for Health and Policy Studies, University of Calgary, Calgary, Alberta, Canada
Arch Intern Med 169:1104-12. 2009..0-12.0 g/dL) and high hemoglobin target levels (>12.0 g/dL) and performed a meta-analysis of all available 36-item short-form (SF-36) RCT data...
Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary diseaseMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am J Kidney Dis 44:832-9. 2004..We conducted this study to determine whether gemfibrozil reduced rates of renal function loss in people with moderate CRI...
Enrolment in primary care networks: impact on outcomes and processes of care for patients with diabetesBraden J Manns
Department of Medicine, University of Calgary, Calgary, Alta
CMAJ 184:E144-52. 2012..We sought to determine the association between enrolment in primary care networks and the care and outcomes of patients with diabetes...
The effect of statins on preservation of kidney function in patients with coronary artery diseaseMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Canada
Curr Opin Cardiol 21:608-12. 2006..This paper outlines evidence for the putative renal benefits of statins in people with vascular disease...
Economic evaluation of continuous renal replacement therapy in acute renal failureScott Klarenbach
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Int J Technol Assess Health Care 25:331-8. 2009..Controversy exists regarding the optimal method of providing dialysis in critically ill patients with acute renal failure. We sought to determine the cost-effectiveness of treatment strategies...
Early recognition and prevention of chronic kidney diseaseMatthew T James
Department of Medicine, University of Calgary, Calgary, AB, Canada
Lancet 375:1296-309. 2010..Novel clinical methods to better identify patients at risk of progression to later stages of chronic kidney disease, including kidney failure, are needed to target management to high-risk subgroups...
Dialysate potassium and risk of death in chronic hemodialysis patientsGhassan Al-Ghamdi
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
J Nephrol 23:33-40. 2010..Few data guide the prescription of dialysate potassium (dK) in hemodialysis, which is usually prescribed empirically on the basis of predialysis serum potassium levels...
The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trialWenjie Wang
Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
Am J Kidney Dis 51:796-803. 2008..Whether increasing dialysis adequacy in large patients not achieving KDOQI targets improves HRQL is unknown...
The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot studyMichael Walsh
Department of Medicine, University of Calgary, Calgary, Canada
BMC Nephrol 7:2. 2006..The impact of NHD on LV mass represents a clinically important outcome which will further elucidate the potential benefits of NHD and guide future clinical endpoint studies...
Access flow in arteriovenous accesses by optodilutional and ultrasound dilution methodsMarcello Tonelli
Department of Medicine, University of Alberta, Alberta, Canada
Am J Kidney Dis 46:933-7. 2005..There has been little exploration of how the use of other devices might affect the feasibility or performance of screening in AV accesses...
Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activatorBrenda R Hemmelgarn
Department of Medicine, University of Calgary, Calgary, Alberta
N Engl J Med 364:303-12. 2011....
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of lifeMichael Walsh
Department of Medicine, University of Calgary, Alberta, Canada
Kidney Int 67:1500-8. 2005..Before significant resources are invested in initiating nocturnal hemodialysis programs, further data on mortality and cardiovascular morbidity, preferably from randomized clinical trials, are required...
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysisBraden J Manns
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Kidney Int 75:542-9. 2009....
Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic reviewMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am J Kidney Dis 51:630-40. 2008..Observational studies indicate that routine measurements of access blood flow and use of Doppler ultrasound improve vascular access outcomes in hemodialysis patients, but randomized trials reached conflicting conclusions...
Best threshold for diagnosis of stenosis or thrombosis within six months of access flow measurement in arteriovenous fistulaeMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Canada
J Am Soc Nephrol 14:3264-9. 2003..It is recommended that clinicians arrange angiography when Qa is <500 ml/min in AVF...
Development of diabetes mellitus following kidney transplantation: a Canadian experienceSita Gourishankar
Division of Nephrology and Transplantation Immunology, 11 108E Clinical Sciences Building, University of Alberta, Edmonton, Alberta, Canada
Am J Transplant 4:1876-82. 2004..This study demonstrates that in a Canadian kidney transplant population that there is a significant risk of PTDM following kidney transplantation, and it is therefore advisable to minimize this risk...
Relation between access blood flow and mortality in chronic hemodialysis patientsMohammed Al-Ghonaim
Department of Medicine, University of Alberta, Edmonton, Canada
Clin J Am Soc Nephrol 3:387-91. 2008..Patients were followed from the date of Qa measurement until death; follow-up was discontinued at loss to follow-up, kidney transplantation, or end of study...
Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysisBraden Manns
Department of Medicine, University of Calgary, Alberta, Canada
J Am Soc Nephrol 16:201-9. 2005..01). Vascular access care is responsible for a significant proportion of health care costs in the first year of hemodialysis. These results support clinical practice guidelines that recommend preferential placement of a native fistula...
Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiencyMarcello Tonelli
Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Kidney Int 66:1123-30. 2004....
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiencyMarcello Tonelli
Division of Nephrology and Immunology, University of Alberta, Clinical Sciences Building, Suite 11-108C, 8440 112 Street, Edmonton, Alberta T6B 2B7, Canada
Ann Intern Med 138:98-104. 2003..Since statins may be underused in this setting, physicians should consider prescribing them for patients with chronic renal insufficiency and known coronary disease...
Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiencyMarcello Tonelli
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
Nephrol Dial Transplant 17:1426-33. 2002..Although the use of these strategies may be increasing, there remains room for improvement. Physicians should remain aware of the need to use these proven strategies in patients with CRI...
Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patientsAminu K Bello
Department of Medicine, University of Alberta, Edmonton, Canada
BMC Nephrol 12:10. 2011..This study focuses on delineating potentially reversible determinants of adverse outcomes that occur in patients receiving dialysis for end-stage renal disease (ESRD)...
Extended reuse of polysulfone hemodialysis membranes using citric acid and heatMarcello Tonelli
Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
ASAIO J 50:98-101. 2004..Increasing the maximum number of uses to 20 may permit cost savings compared with current practice without additional risk...
Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recoveryMarcello Tonelli
Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
Am J Kidney Dis 40:875-85. 2002....
Monitoring and maintenance of arteriovenous fistulae and graft function in haemodialysis patientsMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Canada
Curr Opin Nephrol Hypertens 13:655-60. 2004..Although observational studies show a significant benefit of such strategies, data from randomized trials are limited. This review describes recently published information that has helped to advance this field during the past year...
Optimizing dialysis delivery in tunneled dialysis cathetersNeesh Pannu
Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
ASAIO J 52:157-62. 2006..This suggests that QB in CVC should be set as high as circuit pressure limits will allow, regardless of the potential for AR, and that reversal of line position confers no benefit with respect to solute clearance...
Strategies to reduce the risk of contrast nephropathy: an evidence-based approachNeesh Pannu
Department of Medicine, Division of Nephrology, Alberta, Canada
Curr Opin Nephrol Hypertens 15:285-90. 2006..Recent clinical trials of prophylactic strategies have reported contradictory results. This review presents recent insights into the pathophysiology of contrast nephropathy and reviews trial results in this context...
Statins for improving renal outcomes: a meta-analysisSabrina Sandhu
Department of Medicine, University of Alberta, Edmonton, Alberta T6B 2B7, Canada
J Am Soc Nephrol 17:2006-16. 2006..17 to 0.98). Statin therapy seems to reduce proteinuria modestly and results in a small reduction in the rate of kidney function loss, especially in populations with cardiovascular disease...
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort studyFinlay A McAlister
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
Circulation 109:1004-9. 2004..The prevalence, prognostic import, and impact of renal insufficiency on the benefits of ACE inhibitors and beta-blockers in community-dwelling patients with heart failure are uncertain...
Prophylaxis strategies for contrast-induced nephropathyNeesh Pannu
Department of Medicine, Division of Nephrology, University of Alberta, Edmonton
JAMA 295:2765-79. 2006..Contrast-induced nephropathy is associated with significant economic and clinical consequences, including prolonged hospitalization, the requirement for dialysis, and an increased risk of death...
Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney diseaseDiana Rucker
Department of Medicine, Division of General Internal Medicine, University of Alberta, University of Alberta Hospital, Edmonton, Alberta, Canada
J Nephrol 22:75-82. 2009..We studied persons with both of these risk factors to determine the prevalence of vitamin D insufficiency and whether serum 25-hydroxyvitamin D (25(OH)D) levels were affected by oral vitamin D3 supplementation...
Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recoveryBraden Manns
Department of Medicine, University of Calgary, Alberta, Canada
Crit Care Med 31:449-55. 2003..Because of the high cost of ongoing dialysis, CRRT may still be an economically efficient treatment if it improves renal recovery among survivors; further study in this area is required...
Systematic review of the impact of N-acetylcysteine on contrast nephropathyNeesh Pannu
Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
Kidney Int 65:1366-74. 2004..Before NAC becomes the standard of care for all patients receiving intravenous contrast, new randomized trials evaluating its effect on clinically relevant outcomes are required...
The effect of maintenance immunosuppression medication on the change in kidney allograft functionJohn S Gill
Division of Nephrology, St Paul s Hospital, Vancouver, British Columbia, Canada
Kidney Int 65:692-9. 2004..In this study we determined the effect of maintenance immunosuppression medications on the rate of kidney allograft function loss defined by the annualized change in glomerular filtration rate (GFR)...
The change in allograft function among long-term kidney transplant recipientsJohn S Gill
Division of Nephrology, St. Paul's Hospital, Vancouver, British Columbia, Canada
J Am Soc Nephrol 14:1636-42. 2003..Strategies to improve long-term kidney allograft survival that increase baseline allograft function may be more effective than strategies to slow the decline in GFR...
Influence of dialysis membranes on outcomes in acute renal failureMarcello Tonelli
Kidney Int 63:1957-8; author reply 1958. 2003
Why do preemptive kidney transplant recipients have an allograft survival advantage?John S Gill
Division of Nephrology, St Paul s Hospital Vancouver, BC, Canada
Transplantation 78:873-9. 2004....
Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplastyMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
J Am Soc Nephrol 13:2969-73. 2002..Continued screening after correction of first stenoses appears reasonable, because of both the frequency of recurrent stenosis and the success of repeat intervention...
Patients with Fabry disease on dialysis in the United StatesRavi Thadhani
Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
Kidney Int 61:249-55. 2002..Little is known about the characteristics of patients with Fabry disease that initiate dialysis in the United States, although data from Europe suggests these individuals have a poor survival...
Continuous renal replacement therapyMarcello Tonelli
Can J Anaesth 52:1001-2; author reply 1002. 2005
Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) studyCharmaine E Lok
Nephrology, University Health Network Toronto General Hospital, Toronto, Ontario, Canada
Clin Trials 4:357-67. 2007..The fish oil inhibition of stenosis in hemodialysis grafts (FISH) study evaluates the efficacy of fish oil in improving HD graft patency...
Chronic kidney disease and mortality risk: a systematic reviewMarcello Tonelli
Department of Medicine, University of Alberta, Edmonton, Alberta T6B 2B7, Canada
J Am Soc Nephrol 17:2034-47. 2006..0 in 71% of cohorts. This review supports current guidelines that identify individuals with CKD as being at high risk for cardiovascular mortality. Determining which interventions best offset this risk remains a health priority...
Access to health care among status Aboriginal people with chronic kidney diseaseSong Gao
Department of Medicine, Division of Nephrology, University of Calgary, Calgary, AB
CMAJ 179:1007-12. 2008..We determined whether access to care differed between status Aboriginal people (Aboriginal people registered under the federal Indian Act) and non-Aboriginal people with chronic kidney disease...
Statins for slowing kidney disease progression: an as yet unproven indicationMarcello Tonelli
Am J Kidney Dis 52:391-4. 2008
Comorbidities do not influence primary fistula success in incident hemodialysis patients: a prospective studyWenjie Wang
Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Canada
Clin J Am Soc Nephrol 3:78-84. 2008..Concern about primary fistula failure may contribute to the underuse of arteriovenous fistula. The objective of this study was to investigate the baseline clinical parameters associated with primary fistula success...
